Gene · 3187
HNRNPH1: heterogeneous nuclear ribonucleoprotein H1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. HNRNPH1: heterogeneous nuclear ribonucleoprotein H1. Genes, record 3187. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3187
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P31943 | Heterogeneous nuclear ribonucleoprotein H | 449 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents67
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 7340 | P31943 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 7286 | P31943 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 7286 | P31943 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 7340 | P31943 | Espacenet |
| US 11694765 B2 | 2023-07-04 | 310 | P31943 | Espacenet |
| US 11564998 B2 | 2023-01-31 | 5907 | P31943 | Espacenet |
| US 11564998 B2 | 2023-01-31 | 6820 | P31943 | Espacenet |
| US 11564998 B2 | 2023-01-31 | 7859 | P31943 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 38057 | P31943 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 38058 | P31943 | Espacenet |
1 to 10 of 67
See all 67 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,076
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | HNRNPH1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 10 | 2025 |
| R35GM118136 | Regulation of mRNA processing: Mechanisms and Consequences | 6 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 5 | 2025 |
| P01CA013106 | Targeting Transcription and Splicing in Cancer | 4 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 4 | 2025 |
| ZIABC011704 | Discovery of genes required for expression or activity of fusion oncogenes | 4 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 3 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 3 | 2025 |
| P30ES006694 | Southwest Environmental Health Sciences Center | 3 | 2025 |
| R01GM085319 | Function of Sequence-specific RNA Binding Proteins | 3 | 2025 |
1 to 10 of 1,076Source NIH's project files
See all 1,076 nih grantsPapers1,383
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CHTOP regulates the NRF2/HO-1 axis to modulate chemoresistance in colorectal cancer. | Redox Biol | 2026 | 42617575 | PubTator, text mining | PubMed |
| m6A-dependent regulation of DGUOK-AS1 by RBM15 and HNRNPH1 in lung adenocarcinoma. | iScience | 2026 | 42603931 | PubTator, text mining | PubMed |
| Interplay of telomerase non-canonical functions in NK cell resistance to iCasp9-mediated apoptosis. | Cell Death Discov | 2026 | 42285928 | PubTator, text mining | PubMed |
| Integrative RNA-seq and iRIP-seq analysis links SNRPA overexpression to transcriptomic and splicing alterations in hepatocellular carcinoma cells. | Front Oncol | 2026 | 42147247 | PubTator, text mining | PubMed |
| Roles of RNA-Binding Nuclear Proteins in Alzheimer's Disease Pathophysiology. | ACS Pharmacol Transl Sci | 2026 | 42130721 | PubTator, text mining | PubMed |
| HnRNP H1 binds to nucleocapsid protein and potential guanine-quadruplex site of viral RNA to promote PRRSV-2 proliferation. | Res Vet Sci | 2026 | 41996971 | PubTator, text mining | PubMed |
| An Integrative Analysis of the Role of Mitophagy in Comorbid Myocardial Infarction and Type 2 Diabetes Mellitus. | Endocr Metab Immune Disord Drug Targets | 2026 | 41968706 | PubTator, text mining | PubMed |
| New perspectives on the mechanisms and treatment of valvular heart disease: Mendelian randomization and systematic analysis based on plasma proteins. | Medicine (Baltimore) | 2026 | 41931316 | PubTator, text mining | PubMed |
| Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities. | J Biomed Sci | 2026 | 41928257 | PubTator, text mining | PubMed |
| A quantitative cell-based reporter links TDP-43 aggregation and dysfunction to define pathogenic mechanisms. | PLoS Biol | 2026 | 41875078 | PubTator, text mining | PubMed |
1 to 10 of 1,383
See all 1,383 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3187
GET https://conductscience.org/api/genes/v1/3187/patents?page=2